These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 26127010)

  • 1. Preparation and In Vitro-In Vivo Evaluation of Sustained-Release Matrix Pellets of Capsaicin to Enhance the Oral Bioavailability.
    Zhang Y; Huang Z; Omari-Siaw E; Lu S; Zhu Y; Jiang D; Wang M; Yu J; Xu X; Zhang W
    AAPS PharmSciTech; 2016 Apr; 17(2):339-49. PubMed ID: 26127010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and in vitro/in vivo evaluation of sustained-release venlafaxine hydrochloride pellets.
    Liu Y; Sun Y; Sun J; Zhao N; Sun M; He Z
    Int J Pharm; 2012 Apr; 426(1-2):21-28. PubMed ID: 22266529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of lipid aspirin sustained-release pellets by solvent-free extrusion/spheronization and an investigation of their stability.
    Yan X; He H; Meng J; Zhang C; Hong M; Tang X
    Drug Dev Ind Pharm; 2012 Oct; 38(10):1221-9. PubMed ID: 22713120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and in vitro/in vivo evaluation of esomeprazole magnesium-modified release pellets.
    Kan SL; Lu J; Liu JP; Zhao Y
    Drug Deliv; 2016; 23(3):866-73. PubMed ID: 24892629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
    Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
    Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and in vitro and in vivo characterization of mucoadhesive matrix pellets of metformin hydrochloride for oral controlled release: a technical note.
    Ige PP; Gattani SG
    Arch Pharm Res; 2012 Mar; 35(3):487-98. PubMed ID: 22477196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-Micro-Emulsifying Controlled Release of Eugenol Pellets: Preparation, In vitro/In vivo Investigation in Beagle Dogs.
    Wang Q; Guo M; Adu-Frimpong M; Zhang K; Yang Q; Toreniyazov E; Ji H; Xu X; Cao X; Yu J
    AAPS PharmSciTech; 2019 Aug; 20(7):284. PubMed ID: 31407165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo evaluation of levofloxacin sustained-release capsules.
    Yin LF; Huang SJ; Jiang SG; Zhao CJ; Pei ZQ; Zhang Q
    Drug Dev Ind Pharm; 2011 Jan; 37(1):33-40. PubMed ID: 20545503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.
    Hu LD; Liu Y; Tang X; Zhang Q
    Eur J Pharm Biopharm; 2006 Oct; 64(2):185-92. PubMed ID: 16797948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced oral bioavailability of novel mucoadhesive pellets containing valsartan prepared by a dry powder-coating technique.
    Cao QR; Liu Y; Xu WJ; Lee BJ; Yang M; Cui JH
    Int J Pharm; 2012 Sep; 434(1-2):325-33. PubMed ID: 22688251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eudragit NE40-drug mixed coating system for controlling drug release of core pellets.
    Rahman NU; Yuen KH
    Drug Dev Ind Pharm; 2005 May; 31(4-5):339-47. PubMed ID: 16093199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Losartan potassium sustained release pellets with improved
    Abou Obaid NI; Al-Jenoobi FI; Ibrahim MA; Alam MA
    Pharm Dev Technol; 2020 Nov; 25(9):1031-1042. PubMed ID: 32538215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and in vitro-in vivo evaluation of none gastric resident dipyridamole (DIP) sustained-release pellets with enhanced bioavailability.
    Xu L; Luo Y; Feng J; Xu M; Tao X; He H; Tang X
    Int J Pharm; 2012 Jan; 422(1-2):9-16. PubMed ID: 22001837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and evaluation of ziprasidone-phospholipid complex from sustained-release pellet formulation with enhanced bioavailability and no food effect.
    Miao Y; Chen G; Ren L; Ouyang P
    J Pharm Pharmacol; 2016 Feb; 68(2):185-94. PubMed ID: 26748446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
    Sankalia JM; Sankalia MG; Mashru RC
    J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and evaluation of mefenamic acid sustained release matrix pellets.
    Ibrahim MA
    Acta Pharm; 2013 Mar; 63(1):85-98. PubMed ID: 23482315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.
    Sawant KK; Patel MH; Patel K
    Drug Dev Ind Pharm; 2016; 42(5):758-68. PubMed ID: 26548349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and evaluation of self-nanoemulsifying sustained-release pellet formulation of ziprasidone with enhanced bioavailability and no food effect.
    Miao Y; Chen G; Ren L; Pingkai O
    Drug Deliv; 2016 Sep; 23(7):2163-2172. PubMed ID: 25148542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system.
    Serratoni M; Newton M; Booth S; Clarke A
    Eur J Pharm Biopharm; 2007 Jan; 65(1):94-8. PubMed ID: 17056237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation, characterization, and pharmacokinetics study of capsaicin via hydroxypropyl-beta-cyclodextrin encapsulation.
    Zhao Y; Sun C; Shi F; Firempong CK; Yu J; Xu X; Zhang W
    Pharm Biol; 2016; 54(1):130-8. PubMed ID: 25853954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.